ChemicalBook--->CAS DataBase List--->314728-85-3

314728-85-3

314728-85-3 Structure

314728-85-3 Structure
IdentificationBack Directory
[Name]

Piperazine, 1-benzoyl-4-(1-oxopropyl)-
[CAS]

314728-85-3
[Synonyms]

SunifiraM
Lopac-D-5689
Sunifiram DM235
DM-235;DM 235;DM235
hot selling Sunifiram DM235
top quality Sunifiram DM235
1-Benzoyl-4-propanoylpiperazine
1-Benzoyl-4-(1-oxopropyl)-piperazine
Piperazine, 1-benzoyl-4-(1-oxopropyl)-
1-(4-Benzoylpiperazin-1-yl)propan-1-one
1-(4-Benzoyl-1-piperazinyl)-1-propanone
1-Propanone, 1-(4-benzoyl-1-piperazinyl)-
[EINECS(EC#)]

1312995-182-4
[Molecular Formula]

C14H18N2O2
[MDL Number]

MFCD04112755
[MOL File]

314728-85-3.mol
[Molecular Weight]

246.3
Chemical PropertiesBack Directory
[Melting point ]

92 - 94°C
[Boiling point ]

442.0±38.0 °C(Predicted)
[density ]

1.154±0.06 g/cm3 (20 ºC 760 Torr)
[storage temp. ]

Sealed in dry,2-8°C
[solubility ]

H2O: soluble24mg/mL
[form ]

solid
[pka]

0.08±0.70(Predicted)
[color ]

white
[InChI]

InChI=1S/C14H18N2O2/c1-2-13(17)15-8-10-16(11-9-15)14(18)12-6-4-3-5-7-12/h3-7H,2,8-11H2,1H3
[InChIKey]

DGOWDUFJCINDGI-UHFFFAOYSA-N
[SMILES]

C(N1CCN(C(=O)C2=CC=CC=C2)CC1)(=O)CC
Safety DataBack Directory
[WGK Germany ]

3
Hazard InformationBack Directory
[Description]

Sunifiram (DM235, CAS Number: 314728-85-3) is a novel pyrrolidone nootropic drug that was developed by the Gualtieri research group in 2000. It has a similar structure to piracetam, but it is not classified as a racetam drug due to the breaking of its pyrrolidone backbone. Sunifiram was originally developed to treat neurodegenerative disorders, such as Alzheimer's disease. Compared to piracetam, its anti-amnesiac activity is several orders of magnitude higher on a per-weight basis. The drugs can be helpful in the treatment of neurodegenerative disorders like Alzheimer’s, Parkinson’s, multiple sclerosis, schizophrenia, and attention-deficit hyperactivity disorders.
[Uses]

Sunifiram is a potent nootropic agent.
[Synthesis Reference(s)]

Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers.
DOI: 10.1016/j.bmc.2009.08.055
synthesis of Sunifiram
Novel Sunifiram-carbamate hybrids as potential dual acetylcholinesterase inhibitor and NMDAR co-agonist: simulation-guided analogue design and pharmacological screening
DOI: 10.1080/14756366.2022.2068147
[Side effects]

While initial research suggests that sunifiram is virtually non-toxic and doesn’t produce any notable side effects, it’s important to note how little research has been conducted on this compound. For this reason, it’s incredibly important that you begin with a low dosage before ramping up to a higher one, and pay close attention to any noted side effects you experience.
Based on anecdotal evidence, some sunifiram users have experienced side effects such as:
Headache
Hot flashes
Difficulty sleeping
Manic feelings
These side effects seem only to be mentioned with dosages outside of the 5-10mg range, with higher doses producing more pronounced side effects. If you find that you’re experiencing side effects as you up your dosage, ramp down your dosage to a level where no side effects are present.
[Mode of action]

Sunifiram(314728-85-3) enhances NMDA-dependent signaling by increasing PKCα phosphorylation, at a dosage range of 10-100nM. This mechanism of action is dependent on the availability of the glycine binding site and Sunifiram has been shown to act as an antagonist to glycine at a concentration of 300μM.
Furthermore, the increased activity of AMPA receptor activation has been associated with increased CAMKII and PKCα phosphorylation. Although studies have confirmed that intracellular proteins like CAMKII and PKCα are activated after Sunifiram administration, other proteins like CaMKIV and ERK remain unaffected.
A brief summary of the mechanism of action, as it is currently understood, is that Sunifiram acts on the NMDA receptor’s glycine binding site, which results in increased signaling and activation of CAMKII and PKCα proteins and the subsequent positive regulation of AMPA receptors.
Furthermore, animal studies have indicated that a dosage of 0.01mg/kg increases acetylcholine release by up to 200% within one hour of injection, in rat prefrontal cortex. This effect is not seen at a higher dosage of 1mg/kg.
[References]

[1] Agha, Khalid A. et al. "Novel Sunifiram-carbamate hybrids as potential dual acetylcholinesterase inhibitor and NMDAR co-agonist: simulation-guided analogue design and pharmacological screening." Journal of Enzyme Inhibition and Medicinal Chemistry 37 (2022): 1241–1256. DOI: 10.1080/14756366.2022.2068147
[2] Moriguchi, Shigeki et al. "Novel nootropic drug sunifiram enhances hippocampal synaptic efficacy via glycine‐binding site of N‐methyl‐D‐aspartate receptor." Hippocampus 23 (2013). DOI: 10.1002/hipo.22150
314728-85-3 suppliers list
Company Name: Wuhan senwayer century chemical Co.,Ltd
Tel: +undefined-27-86652399 +undefined13627115097 , +undefined13627115097
Website: http://www.senwayer.com/
Company Name: Shanghai Chinqesen Biotechnology Co., Ltd.
Tel: +86-16628886292 +86-19521323435 , +86-19521323435
Website: qschem-pharma.com/
Company Name: Hebei Mojin Biotechnology Co., Ltd
Tel: +8613288715578 , +8613288715578
Website: www.mojinchemical.com
Company Name: Hong Kong Excellence Biotechnology Co., Ltd.
Tel: +86-86-18838029171 +8618126314766 , +8618126314766
Website: www.chemicalbook.com/showsupplierproductslist1274886/0.htm
Company Name: ANHUI SHENGZHIKAI BIOTECHNOLOGY CO.,LTD
Tel: +8619155187336 , +8619155187336
Website: www.chemicalbook.com/showsupplierproductslist101106/0_en.htm
Company Name: Wuhan Marco Pharmaceutical Technology Co., Ltd.
Tel: +86-86-18572802410 +8618572802410 , +8618572802410
Website: marcopht.com
Company Name: Hebei Xinsheng New Material Technology Co., LTD.
Tel: +86-16632316109 , +86-16632316109
Website: www.xsmaterial.com/admin/
Company Name: Anhui Ruihan Technology Co., Ltd
Tel: +8617756083858 , +8617756083858
Website: www.chemicalbook.com/manufacturer/anhui-ruihan-technology/
Company Name: Sigma Audley
Tel: +86-18336680971 +86-18126314766 , +86-18126314766
Website:
Company Name: Henan Tianfu Chemical Co.,Ltd.
Tel: +86-0371-55170693 +86-19937530512 , +86-19937530512
Website: https://www.tianfuchem.com/
Company Name: Nanjing Finetech Chemical Co., Ltd.
Tel: 025-85710122 17714198479
Website: www.fine-chemtech.com
Company Name: career henan chemical co
Tel: +86-0371-86658258
Website: https://www.coreychem.com/
Company Name: TianYuan Pharmaceutical CO.,LTD
Tel: +86-755-23284190 13684996853
Website: www.tianpharm.com
Company Name: Jinan Carbotang Biotech Co.,Ltd.
Tel: +8615866703830 , +8615866703830
Website: https://www.chemicalbook.com/ShowSupplierProductsList31189/0.htm
Company Name: Cangzhou Wanyou New Material Technology Co.,Ltd
Tel: 18631714998
Website: www.chemicalbook.com/ShowSupplierProductsList1382651/0.htm
Company Name: Xi'an Kono chem co., Ltd.,
Tel: 029-86107037 13289246953 , 13289246953
Website: www.konochem.com
Company Name: Shandong chuangyingchemical Co., Ltd.
Tel: 18853181302
Website: www.chemicalbook.com/ShowSupplierProductsList103425/0.htm
Company Name: Shanghai Longyu Biotechnology Co., Ltd.
Tel: +8615821988213 , +8615821988213
Website: https://www.chemicalbook.com/manufacturer/shanghai-longyu-biotechnology-164/
Tags:314728-85-3 Related Product Information
272786-64-8 18903-04-3 78019-77-9 546-88-3 3286-46-2 845273-93-0 107-73-3